DekaBank Deutsche Girozentrale »

Catalyst Pharmaceutical Partners shares owned by DekaBank Deutsche Girozentrale

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by DekaBank Deutsche Girozentrale from 13F filings

Historical chart of DekaBank Deutsche Girozentrale investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by DekaBank Deutsche Girozentrale consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by DekaBank Deutsche Girozentrale

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.8M 171k 16.13
2023-09-30 $236k 20k 11.80

More positions owned by DekaBank Deutsche Girozentrale

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Accenture Plc Ireland Shs Class A (ACN)
Abbvie (ABBV)

View all positions for DekaBank Deutsche Girozentrale

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
LSV Asset Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners